Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

The comparison of effects of biologic agents on rheumatoid arthritis damage progression is biased by period of enrollment: data from a systematic review and meta-analysis.

Favalli EG, Pregnolato F, Biggioggero M, Meroni PL.

Semin Arthritis Rheum. 2014 Jun;43(6):730-7. doi: 10.1016/j.semarthrit.2013.11.006. Epub 2013 Nov 13. Review.

PMID:
24332807
3.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

4.

Radiological outcomes in randomized controlled trials on biologic therapies for rheumatoid arthritis: a narrative review.

Bizzi E, Massafra U, Laganà B, Bruzzese V, Diamanti AP, Cassol M, Migliore A.

Clin Rheumatol. 2014 Jul;33(7):877-84. doi: 10.1007/s10067-014-2504-7. Epub 2014 Feb 8. Review.

PMID:
24510026
5.

Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis.

Aaltonen KJ, Virkki LM, Malmivaara A, Konttinen YT, Nordström DC, Blom M.

PLoS One. 2012;7(1):e30275. doi: 10.1371/journal.pone.0030275. Epub 2012 Jan 17. Review.

6.

Correlation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agents.

Ikeda K, Nakagomi D, Sanayama Y, Yamagata M, Okubo A, Iwamoto T, Kawashima H, Takahashi K, Nakajima H.

J Rheumatol. 2013 Dec;40(12):1967-76. doi: 10.3899/jrheum.130556. Epub 2013 Nov 1.

PMID:
24187096
8.

Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.

Wells AF, Westhovens R, Reed DM, Fanti L, Becker JC, Covucci A, Keystone EC.

J Rheumatol. 2011 Nov;38(11):2362-8. doi: 10.3899/jrheum.110054. Epub 2011 Sep 1.

9.
11.

Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study.

Takeuchi T, Yamanaka H, Ishiguro N, Miyasaka N, Mukai M, Matsubara T, Uchida S, Akama H, Kupper H, Arora V, Tanaka Y.

Ann Rheum Dis. 2014 Mar;73(3):536-43. doi: 10.1136/annrheumdis-2012-202433. Epub 2013 Jan 11.

12.

Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials.

Goulabchand R, Mouterde G, Barnetche T, Lukas C, Morel J, Combe B.

Ann Rheum Dis. 2014 Feb;73(2):414-9. doi: 10.1136/annrheumdis-2012-202641. Epub 2013 Jan 25. Review.

PMID:
23355079
13.

Biologics for rheumatoid arthritis: an overview of Cochrane reviews.

Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Tanjong Ghogomu E, Tugwell P.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007848. doi: 10.1002/14651858.CD007848.pub2. Review.

PMID:
19821440
14.

Is it possible to withdraw biologics from therapy in rheumatoid arthritis?

Tanaka Y, Hirata S.

Clin Ther. 2013 Dec;35(12):2028-35. doi: 10.1016/j.clinthera.2013.10.008. Epub 2013 Nov 28. Review.

PMID:
24290736
15.

Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis.

Emery P, Genovese MC, van Vollenhoven R, Sharp JT, Patra K, Sasso EH.

J Rheumatol. 2009 Jul;36(7):1429-41. doi: 10.3899/jrheum.081018. Epub 2009 Apr 15. Erratum in: J Rheumatol. 2010 Oct;37(10):2198. J Rheumatol. 2010 May;37(5):1081.

PMID:
19369462
16.

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.

Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Ghogomu ET, Tugwell P.

CMAJ. 2009 Nov 24;181(11):787-96. doi: 10.1503/cmaj.091391. Epub 2009 Nov 2. Erratum in: CMAJ. 2010 May 18;182(8):806.

17.
18.

The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy.

Emery P, Fleischmann R, van der Heijde D, Keystone EC, Genovese MC, Conaghan PG, Hsia EC, Xu W, Baratelle A, Beutler A, Rahman MU.

Arthritis Rheum. 2011 May;63(5):1200-10. doi: 10.1002/art.30263. Erratum in: Arthritis Rheum. 2012 Apr;64(4):1045.

19.

Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis: a two-year, double-blind, randomized study.

Emery P, Breedveld F, van der Heijde D, Ferraccioli G, Dougados M, Robertson D, Pedersen R, Koenig AS, Freundlich B; Combination of Methotrexate and Etanercept in Early Rheumatoid Arthritis Trial Group.

Arthritis Rheum. 2010 Mar;62(3):674-82. doi: 10.1002/art.27268. Erratum in: Arthritis Rheum. 2010 Oct;62(10):3005.

20.

Meta-analysis of clinical and radiological efficacy of biologics in rheumatoid arthritis patients naive or inadequately responsive to methotrexate.

Pierreisnard A, Issa N, Barnetche T, Richez C, Schaeverbeke T.

Joint Bone Spine. 2013 Jul;80(4):386-92. doi: 10.1016/j.jbspin.2012.09.023. Epub 2012 Nov 7. Review.

PMID:
23141718
Items per page

Supplemental Content

Write to the Help Desk